Status:
COMPLETED
Evaluation of Tuberculosis Treatment Outcomes
Lead Sponsor:
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Brief Summary
Tuberculosis (TB) is an infectious disease caused by Mycobacterium species grouped in the Mycobacterium tuberculosis complex. TB remains a major global health problem, despite the fact that there are ...
Detailed Description
Tuberculosis (TB) is an infectious disease caused by Mycobacterium species grouped in the Mycobacterium tuberculosis complex. TB remains a major global health problem, despite the fact that there are ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients aged ≥18 years
- Patients with tuberculosis with microbiological confirmation
- Patients notified to the SS Surveillance and Control Hospital Infections Antimicrobial Stewardship of the Alexandria Hospital Company from 2019 to 2023
- Patients taken in charge by the SC Infectious Diseases of the Alexandria Hospital Company for whom MOD B has been completed
- Obtaining informed consent
Exclusion
Key Trial Info
Start Date :
May 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2023
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT06942975
Start Date
May 8 2023
End Date
December 12 2023
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trial Center
Alessandria, Italy, Italy, 15121